Structural characterization of the D290V mutation site in hnRNPA2 low-complexity-domain polymers.
Dylan T MurrayXiaoming ZhouMasato KatoSiheng XiangRobert TyckoSteven L McKnightPublished in: Proceedings of the National Academy of Sciences of the United States of America (2018)
Human genetic studies have given evidence of familial, disease-causing mutations in the analogous amino acid residue shared by three related RNA binding proteins causative of three neurological diseases. Alteration of aspartic acid residue 290 of hnRNPA2 to valine is believed to predispose patients to multisystem proteinopathy. Mutation of aspartic acid 262 of hnRNPA1 to either valine or asparagine has been linked to either amyotrophic lateral sclerosis or multisystem proteinopathy. Mutation of aspartic acid 378 of hnRNPDL to either asparagine or histidine has been associated with limb girdle muscular dystrophy. All three of these aspartic acid residues map to evolutionarily conserved regions of low-complexity (LC) sequence that may function in states of either intrinsic disorder or labile self-association. Here, we present a combination of solid-state NMR spectroscopy with segmental isotope labeling and electron microscopy on the LC domain of the hnRNPA2 protein. We show that, for both the wild-type protein and the aspartic acid 290-to-valine mutant, labile polymers are formed in which the LC domain associates into an in-register cross-β conformation. Aspartic acid 290 is shown to be charged at physiological pH and immobilized within the polymer core. Polymers of the aspartic acid 290-to-valine mutant are thermodynamically more stable than wild-type polymers. These observations give evidence that removal of destabilizing electrostatic interactions may be responsible for the increased propensity of the mutated LC domains to self-associate in disease-causing conformations.
Keyphrases
- wild type
- amino acid
- muscular dystrophy
- amyotrophic lateral sclerosis
- end stage renal disease
- endothelial cells
- newly diagnosed
- chronic kidney disease
- mass spectrometry
- solid state
- prognostic factors
- electron microscopy
- induced pluripotent stem cells
- liquid chromatography
- protein protein
- capillary electrophoresis
- cerebral ischemia
- brain injury
- tandem mass spectrometry
- drug induced